Fluocinolone Acetonide Intravitreal Implant 0.19 mg (ILUVIEN®): A Review in Diabetic Macular Edema
Sign Up to like & getrecommendations! Published in 2017 at "Drugs"
DOI: 10.1007/s40265-017-0722-4
Abstract: Fluocinolone acetonide intravitreal implant 0.19 mg (ILUVIEN®) is a nonbiodegradable, injectable, corticosteroid implant that is approved in several countries, including the USA, for the treatment of diabetic macular edema (DME). ILUVIEN® releases fluocinolone acetonide at an… read more here.
Keywords: acetonide intravitreal; implant iluvien; fluocinolone acetonide; intravitreal implant ... See more keywords
Preliminary evaluation of YUTIQ™ (fluocinolone acetonide intravitreal implant 0.18 mg) in posterior uveitis.
Sign Up to like & getrecommendations! Published in 2019 at "Therapeutic delivery"
DOI: 10.4155/tde-2019-0051
Abstract: Uveitis is a major cause of ocular morbidity, potentially leading to significant visual impairment. The recent adoption of alternative drug delivery options has led to the development of new sustained-delivery corticosteroid systems, able to manage… read more here.
Keywords: posterior uveitis; intravitreal implant; fluocinolone acetonide; acetonide intravitreal ... See more keywords